Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avrobio Inc (AVRO)
NASDAQ:AVRO
Avrobio (AVRO) Stock Price & Analysis
301 Followers
AVRO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.57 - $1.93
Previous Close$1.59
Volume145.43K
Average Volume (3M)467.73K
Market Cap
$70.80M
Enterprise Value-$51.78M
Total Cash (Recent Filing)$124.97M
Total Debt (Recent Filing)$2.38M
Price to Earnings (P/E)-11.4
Beta1.96
Next Earnings
Nov 09, 2023EPS Estimate
-$0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding44,530,744
10 Day Avg. Volume300,803
30 Day Avg. Volume467,725
Standard Deviation0.24
R-Squared0.13
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.57
Price to Sales (P/S)3020.35
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-750.49
Enterprise Value/Gross Profit-17.30
Enterprise Value/Ebitda14.29
Forecast
1Y Price Target
$4.00Price Target Upside151.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Avrobio News
Pre-EarningsAVRO Upcoming Earnings Report: What to Expect?
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AVRO FAQ
What was Avrobio Inc’s price range in the past 12 months?
Avrobio Inc lowest stock price was $0.57 and its highest was $1.93 in the past 12 months.
What is Avrobio Inc’s market cap?
Currently, no data Available
When is Avrobio Inc’s upcoming earnings report date?
Avrobio Inc’s upcoming earnings report date is Nov 09, 2023 which is in 22 days.
How were Avrobio Inc’s earnings last quarter?
Avrobio Inc released its earnings results on Aug 10, 2023. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of -$0.541 by $2.061.
Is Avrobio Inc overvalued?
According to Wall Street analysts Avrobio Inc’s price is currently Undervalued.
Does Avrobio Inc pay dividends?
Avrobio Inc does not currently pay dividends.
What is Avrobio Inc’s EPS estimate?
Avrobio Inc’s EPS estimate is -$0.35.
How many shares outstanding does Avrobio Inc have?
Avrobio Inc has 44,530,743 shares outstanding.
What happened to Avrobio Inc’s price movement after its last earnings report?
Avrobio Inc reported an EPS of $1.52 in its last earnings report, beating expectations of -$0.541. Following the earnings report the stock price went up 0.645%.
Which hedge fund is a major shareholder of Avrobio Inc?
Among the largest hedge funds holding Avrobio Inc’s share is GMT Capital Corp. It holds Avrobio Inc’s shares valued at 2M.
---
Avrobio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (151.57% Upside)
$4.00 (151.57% Upside)
Blogger Sentiment
Bullish
AVRO Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 4.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
161.94%
12-Months-Change
Fundamentals
Return on Equity
-4.56%
Trailing 12-Months
Asset Growth
-8.49%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Avrobio Inc
Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on gene therapy for fabry, gaucher, pompe disease, and cystinosis. These gene therapies, on which the company was founded, were developed by Dr. Jeffrey Medin and Dr. Christopher Paige at the University Health Network. AvroBio launched in 2015, is headed by Co-Founder, President and CEO Geoff Mackay, and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding AVRO
Vanguard Total Stock Market ETF
$1.58M
iShares Core S&P Total U.S. Stock Market ETF
$70.20
Up to five ETFs with an Outperform Smart Score that hold AVRO. The ETFs are listed according to market value of AVRO within the ETF
BioMarin Pharmaceutical
―
Adverum Biotechnologies
―
Rocket Pharmaceuticals
―
Allogene Therapeutics
―
---